1-7 of 7
Luigi Nezi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT167: Neoadjuvant ipilimumab/nivolumab in locally advanced or oligometastatic melanoma: An open label, single arm, multi-institutional clinical study with molecular and immunological biomarker’s analysis

Pier Francesco Ferrucci, Bruno Achutti Duso, Luigi Nezi, Luca Mazzarella, Fiorenza Lotti, Sara Gandini, Gianmarco Orsolini, Elisabetta Pennacchioli, Patrizia Gnagnarella, Teresa Manzo, Simone Ribero, Maria Teresa Fierro, Rebecca Senetta, Concetta Riviello, Virginia Caliendo, Pietro Quaglino, Massino Barberis, Giuseppina Bonizzi, Emilia Cocorocchio
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT167.
https://doi.org/10.1158/1538-7445.AM2022-CT167
Published: 15 June 2022
View article titled, Abstract CT167: Neoadjuvant ipilimumab/nivolumab in locally advanced or oligometastatic melanoma: An open label, single arm, multi-institutional clinical study with molecular and immunological biomarker’s analysis
Journal Articles

Abstract I11: Targeting pancreatic cancer with TCR-engineered T cells

Philip D. Greenberg, Kristin G. Anderson, Dan Egan, Sunil R. Hingorani, Luigi Nezi, Teresa Manzo, Shannon K. Oda, Kelly G. Paulson, Rachel Perret, Leah Schmidt, Tom M. Schmitt, Ingunn M. Stromnes, Aude G. Chapuis
Journal: Cancer Research
Cancer Res (2019) 79 (24_Supplement): I11.
https://doi.org/10.1158/1538-7445.PANCA19-I11
Published: 13 December 2019
View article titled, Abstract I11: Targeting pancreatic cancer with TCR-engineered T cells
Journal Articles

Abstract 976: Metabolic eradication of treatment resistant cancer stem cells in pancreatic tumors: A clonal tracking-based platform for identifying the best personalized treatment

Denise Corti, Alessandro Carugo, Seth Sahil, Matteo Marchesini, Piergiorgio Pettazzoni, Luigi Nezi, Tessa Green, Joseph R Marszalek, Maria Emilia Di Francesco, Timothy P Heffernan, Giulio F Draetta, Andrea Viale
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 976.
https://doi.org/10.1158/1538-7445.AM2015-976
Published: 01 August 2015
View article titled, Abstract 976: Metabolic eradication of treatment resistant cancer stem cells in pancreatic tumors: A clonal tracking-based platform for identifying the best personalized treatment
Journal Articles

Abstract 1701: Identification of epigenetic modifiers able to suppress growth of pancreatic ductal adenocarcinoma: A patient-oriented in vivo functional platform

Alessandro Carugo, Giannicola Genovese, Sahil Seth, Luigi Nezi, Johnathon L. Rose, Andrea Viale, Piergiorgio F. Pettazzoni, Angelo Cicalese, Daniela Bossi, Wantong Yao, Jason B. Fleming, Luisa Lanfrancone, Timothy P. Heffernan, Giulio F. Draetta
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1701.
https://doi.org/10.1158/1538-7445.AM2015-1701
Published: 01 August 2015
View article titled, Abstract 1701: Identification of epigenetic modifiers able to suppress growth of pancreatic ductal adenocarcinoma: A patient-oriented <em>in vivo</em> functional platform
Journal Articles

Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer

Piergiorgio Pettazzoni, Andrea Viale, Parantu Shah, Alessandro Carugo, Haoqiang Ying, Huamin Wang, Giannicola Genovese, Sahil Seth, Rosalba Minelli, Tessa Green, Emmet Huang-Hobbs, Denise Corti, Nora Sanchez, Luigi Nezi, Matteo Marchesini, Avnish Kapoor, Wantong Yao, Maria E. Di Francesco, Alessia Petrocchi, Angela K. Deem, Kenneth Scott, Simona Colla, Gordon B. Mills, Jason B. Fleming, Timothy P. Heffernan, Philip Jones, Carlo Toniatti, Ronald A. DePinho, Giulio F. Draetta
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (6): 1091–1101.
https://doi.org/10.1158/0008-5472.CAN-14-1854
Published: 12 March 2015
View article titled, Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer
Open the PDF for Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract C72: A mechanistic link between whole‐chromosome aneuploidy and DNA damage

Karen Crasta, Luigi Nezi, Morgan Hennessy, Lisa Cameron, Yunfeng Pan, Dipanjan Chowdhury, David Pellman
Journal: Cancer Research
Cancer Res (2009) 69 (23_Supplement): C72.
https://doi.org/10.1158/0008-5472.FBCR09-C72
Published: 28 October 2014
View article titled, Abstract C72: A mechanistic link between whole‐chromosome aneuploidy and DNA damage
Journal Articles

Abstract B67: A mechanistic link between whole‐chromosome aneuploidy and DNA damage

Karen Crasta, Luigi Nezi, Morgan Hennessy, Lisa Cameron, Yunfeng Pan, Dipanjan Chowdhury, David Pellman
Journal: Cancer Research
Cancer Res (2009) 69 (23_Supplement): B67.
https://doi.org/10.1158/0008-5472.FBCR09-B67
Published: 28 October 2014
View article titled, Abstract B67: A mechanistic link between whole‐chromosome aneuploidy and DNA damage